Heart failure progressively worsens over time, with patients with ATTR amyloidosis experiencing progressive diastolic dysfunction, elevated biomarkers (eg, troponin I, BNP or NT-proBNP), rapid decline in functional capacity, and a decrease in LV ejection fraction (LV-EF) [17]. The gene discussed is NPPB; the disease is heart failure.